Locations Main Campus: Chesterfield, MO 63017   |   Locations
314-434-1500 314-434-1500   |   Contact Us
Locations Search Close Menu

Monoclonal Antibody Infusion Therapy for Outpatient Treatment of COVID-19

Casirivimab /imdevimab are investigational monoclonal antibodies used for the treatment of COVID-19 in non-hospitalized adults. They are potent antispike neutralizing monoclonal antibodies designed to mimic the body's natural immune response by binding to the receptor-binding domain of SARS-CoV-2. Monoclonal antibody (mAB) therapy is indicated for the treatment of mildly symptomatic COVID-19 outpatients who are at high risk of progressing to moderate or severe disease. St. Luke's network offers outpatient infusions of casirivimab/imdevimab at St. Luke's Des Peres Hospital. (This page updated 9/15/2021)

The attached physician packet contains all the needed documentation to screen, educate, consent, and schedule your qualifying patient for Outpatient Monoclonal Infusion Therapy at St. Luke's Des Peres Hospital. It includes:
  • Monoclonal Antibody Information Sheet
  • Talking Points for Ordering Physicians
  • Screening Questions and Order Form
  • EUA Fact Sheet for Patients and Caregivers
  • Informed Consent Form
  • Patient Brochure
For more information, call 314-966-9463.

Download the Entire
Physician Packet (PDF)
Download Informed Consent